Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

ENCYSIVE PHARMACEUTICALS INC (ENCY) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $2.34 Metrics
OS: 78.6 B
Market cap: $184 B
Net debt: $173 M
EV: $184 B

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
Revenues19.014.012.811.010.4
            Revenue growth35.6%9.2%17.2%5.0% 
Cost of goods sold0.10.00.029.428.6
Gross profit18.914.012.8-18.4-18.2
            Gross margin99.5%100.0%100.0%-168.1%-174.4%
Selling, general and administrative   8.3 
Sales and marketing41.416.03.2  
Research and development64.463.556.4  
General and administrative22.312.38.4 9.0
EBIT-109.3-77.8-55.2-26.7-27.2
            EBIT margin-575.3%-555.4%-430.0%-243.6%-260.4%
Pre-tax income-109.4-76.2-53.7-33.80.0
Income taxes-109.4-77.5-52.8-32.30.0
            Tax rate100.0%101.8%98.3%95.5% 
Earnings from continuing ops-109.3-76.2-53.7-33.8-23.5
Earnings from discontinued ops 1.3-0.9-1.5 
Net income-109.3-74.9-54.7-35.3-23.5
            Net margin-575.3%-534.6%-426.0%-322.3%-224.9%
 
Diluted EPS($1,863.94)($1,314.93)($996.05)($0.77)($536.54)
Shares outstanding (diluted)0.10.10.144.10.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy